On March 11, 2022, Mr. Brian Achenbach notified Mustang Bio, Inc. (the 'Company') that he was resigning from his role as the Company's Senior Vice President of Finance & Corporate Controller, effective March 27, 2022, to pursue an opportunity outside of the Company. Mr. Achenbach did not resign as a result of any disagreement with the Company on any matter relating to the Company's operations, financial reporting or controls. The Company has entered into a consulting arrangement with Mr. Achenbach effective March 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1485 USD | -4.19% | -26.19% | -89.00% |
05-15 | Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-02 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.00% | 4.18M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- MBIO Stock
- News Mustang Bio, Inc.
- Brian Achenbach Resigns as Senior Vice President of Finance & Corporate Controller of Mustang Bio, Inc., Effective March 27, 2022